Abbott Laboratories CEO calls post-earnings stock decline ‘a little bit of an overreaction' [CNBC]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: CNBC
a Thursday interview with CNBC's Jim Cramer, saying that Wall Street's reaction to the results was too extreme. “I think this is a little bit of an overreaction. Of course, we are all over this,” Ford said. “We're focused on this, but the fundamentals of the entire rest of the company are pretty much intact, and this is just really a point in time that we have to get through.” CEO Robert Ford unpacked his company's latest quarterly in a Thursday interview with CNBC's , saying that Wall Street's reaction to the results was extreme. “I think this is a little bit of an overreaction. Of course, we are all over this,” Ford said. “We're focused on this, but the fundamentals of the entire rest of the company are pretty much intact, and this is just really a point in time that we have to get through.” While Abbott posted a top and bottom line beat for the second quarter, investors were disappointed that the company tightened its full-year earnings guidance. Shares were down more than
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise [Seeking Alpha]Seeking Alpha
- Abbott Laboratories (NYSE:ABT) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns? [Yahoo! Finance]Yahoo! Finance
- Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation [Yahoo! Finance]Yahoo! Finance
- Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial FibrillationPR Newswire
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/23/25 - Form 3
- 12/19/25 - Form 3
- 12/12/25 - Form 4
- ABT's page on the SEC website